BUSINESS DEVELOPMENT

DURECT’s business strategy includes the establishing of partnerships with other biotechnology and pharmaceutical companies. This type of collaboration usually takes one of two forms:

  • Licensing product candidates that are already in development to another company for further development and commercialization
  • Licensing one of our proprietary drug delivery technologies for a specific application, and providing a dedicated team of scientists and formulators to assist in the development of a pharmaceutical product that achieves the desired goals

If you represent a biotechnology or pharmaceutical company interested in discussing partnering opportunities with DURECT, please contact:

Michael Arenberg, J.D., M.B.A.
Senior Vice President, Corporate and Business Development
Phone: 408-346-1052
mike.arenberg@durect.com